• GSK621 in Immunometabolic Research: Precision AMPK Agonist f

  2026-06-19

  Explore how GSK621, a potent AMPK agonist, uniquely advances immunometabolic and acute myeloid leukemia research by enabling precise manipulation of metabolic pathways and immune cell phenotypes. This article provides advanced protocol guidance, mechanistic insights, and a critical analysis of recent breakthroughs.

• Scenario-Driven Solutions Using T7 RNA Polymerase (SKU K1083

  2026-06-19

  This article guides biomedical researchers through practical laboratory scenarios where T7 RNA Polymerase (SKU K1083) addresses reproducibility, throughput, and assay design challenges. With data-backed analysis and direct protocol references, readers will understand how this recombinant enzyme expressed in E. coli delivers reliability and specificity for in vitro transcription, RNA vaccine production, and RNAi research.

• Everolimus (RAD001): Reliable mTOR Inhibitor for Cancer Rese

  2026-06-18

  This scenario-driven article addresses real-world laboratory challenges in cell viability and proliferation assays, highlighting how Everolimus (RAD001) (SKU A8169) ensures reproducible, high-quality data. Drawing on validated protocols and scientific literature, it demonstrates the practical advantages of this mTOR inhibitor for bench scientists.

• MitMAB (SKU B7620): Reliable Control for Endocytosis Researc

  2026-06-18

  MitMAB (N,N,N-trimethyltetradecan-1-aminium bromide, SKU B7620) provides bench scientists with a high-purity, reproducible inhibitor for dissecting dynamin-dependent endocytosis in complex cellular and organoid models. This article presents scenario-driven, evidence-based answers to common experimental challenges, emphasizing MitMAB's validated advantages for reliable intracellular trafficking studies.

• Capsazepine: Applied TRPV1 Ion Channel Antagonist Workflows

  2026-06-17

  Capsazepine is a cornerstone for dissecting TRPV1-dependent pain and apoptosis mechanisms, enabling precise in vitro and in vivo assay design. This article translates recent methodological advances into actionable protocols, distinguishes Capsazepine’s unique value for nociception and cancer research, and delivers troubleshooting insights to maximize experimental reproducibility.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-06-17

  The AO/PI Double Staining Kit enables rapid, differential assessment of cell viability, apoptosis, and necrosis using robust fluorescent dyes. It is suited to cell biology workflows requiring clear discrimination of cell states, but is not intended for applications outside viability, apoptosis, or necrosis detection. Researchers should adhere to storage and handling protocols to ensure reliable results.

• Letrozole: Non-Steroidal Aromatase Inhibitor for Research Pr

  2026-06-16

  Letrozole empowers bench scientists with precise, reversible suppression of estrogen biosynthesis, enabling reproducible modulation of key signaling pathways in breast cancer and neuroendocrine research. This guide unpacks actionable workflows, troubleshooting insights, and protocol optimizations that leverage Letrozole's unique properties for advanced hormone-dependent models.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe): Protocols

  2026-06-16

  Angiotensin II (SKU A1042) is an endogenous octapeptide used to model hypertension mechanisms, cardiovascular remodeling, and vascular injury in preclinical workflows. It is not intended for diagnostic or medical use and requires strict adherence to preparation and storage guidelines for reproducibility in cell and animal studies.

• ECL Western Blotting Substrate: Technical Use and Protocol P

  2026-06-15

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of horseradish peroxidase-conjugated proteins in chemiluminescent Western blot assays. It is best used for workflows in molecular biology, cancer biology, and signal transduction pathway research, but is not suited for protocols requiring fluorescent or radioisotopic detection.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Mechan

  2026-06-15

  This article examines a recent study demonstrating that intravesical delivery of lipid nanoparticles loaded with p21 mRNA can restore tumor suppressor function and suppress tumor growth in bladder cancer. The findings highlight a clinically relevant, localized mRNA therapy approach, with implications for advancing non–muscle-invasive bladder cancer treatment.

• Applied Workflows with Ertugliflozin (PF-04971729) in Resear

  2026-06-14

  Ertugliflozin (PF-04971729) empowers diabetes and inflammation research with exceptional SGLT2 selectivity, robust solubility in organic solvents, and translational protocol flexibility. Discover how to optimize experimental design, troubleshoot workflow bottlenecks, and leverage the latest comparative insights for reliable, reproducible outcomes.

• 4-Hydroxytamoxifen: Protocol Guidance for Reproducible Resea

  2026-06-13

  4-Hydroxytamoxifen is a high-purity estrogen receptor modulator designed for in vitro and in vivo workflows where precise DMSO-based dosing and estrogen receptor selectivity are required. It is unsuitable for protocols demanding ethanol or aqueous solubility, and improper storage or solvent use can compromise experimental reproducibility.

• Reactive Oxygen Species Assay Kit: Advancing Mechanistic Ins

  2026-06-12

  Discover how the Reactive Oxygen Species Assay Kit enables precise ROS quantification in live cells and empowers research into oxidative stress and disease mechanisms. This in-depth analysis integrates assay chemistry, protocol design, and translational insights for advanced apoptosis and oxidative damage studies.

• Computationally Designed Antibodies Enable Dual Detection of

  2026-06-12

  This study introduces a computational chemistry-guided strategy for developing monoclonal antibodies that simultaneously detect lethal amatoxins and phallotoxins in mushrooms. The resulting dual-target fluorescent immunochromatographic assay provides a rapid, sensitive, and cost-effective tool for food safety and toxicology research, with significant implications for public health.

• Neutrophil Extracellular Traps in CML: TKI Impact and Mechan

  2026-06-11

  This article reviews recent evidence showing that neutrophil extracellular trap (NET) formation is heightened in chronic myeloid leukemia (CML), with tyrosine kinase inhibitors (TKIs) modulating this process in distinct ways. The findings clarify an emerging mechanistic link between CML therapies and vascular risk, with practical implications for translational researchers investigating kinase inhibitor effects.

450 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page